[Zidovudine in the treatment of HIV-related thrombocytopenia. A study of 11 cases].
HIV-related thrombocytopenia sometimes requires a therapeutic choice: current therapies are similar to those applied in idiopathic thrombocytopenic purpura. Some Authors described a positive effect on platelets with Zidovudine (AZT) administration. We evaluated the efficacy of this drug in a group of 11 HIV-seropositive patients. Our results were not encouraging: increase in platelet count was obtained in a few patients only and it generally was of little importance.
Steidl
L
L
Divisione di Medicina generale, Università di Pavia, Sede di Varese.
Gussoni
G
G
Montanari
M
M
Crippa
G
G
D000328:Adult; D004341:Drug Evaluation; D006679:HIV Seropositivity / Q000150:complications*; D006801:Humans; D008297:Male; D010976:Platelet Count; D013921:Thrombocytopenia / Q000188:drug therapy* / Q000209:etiology; D015215:Zidovudine / Q000008:administration & dosage / Q000627:therapeutic use*
D015215:Zidovudine
La zidovudina nel trattamento della piastrinopenia HIV-correlata. Uno studio di 11 casi.